Key result
Bay a 1040 (60mg daily) demonstrated outstanding preventive efficacy on the occurrence of anginal attacks in patients with ischemic heart disease.
Why the study?
Does Bay a 1040 improve hemodynamics and prevent anginal attacks in dogs and patients with ischemic heart disease?
Population
Closed-chest and open-chest dogs, and middle-aged patients with ischemic heart disease
Comparison
Bay a 1040 vs Cross-over design control
Design
Other
Authors
Loading...
May support angina prevention in select patients; leaves open its role versus contemporary therapies.
RCT
Cross-over
Does Bay a 1040 improve hemodynamics and prevent anginal attacks in dogs and patients with ischemic heart disease?
Bay a 1040 demonstrates coronary and systemic vasodilatory properties and prevents anginal attacks in patients with ischemic heart disease.
Hayase et al. (1971) conducted an RCT in Ischemic heart disease. Bay a 1040 was evaluated on Occurrence of anginal attacks. Bay a 1040 (60mg daily) demonstrated outstanding preventive efficacy on the occurrence of anginal attacks in patients with ischemic heart disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: